14.03.2017 • News

Nexeo Solutions to Acquire Mexico’s Ultra Chem

(c) Lichtmeister/Shutterstock
(c) Lichtmeister/Shutterstock

Nexeo Solutions has agreed to acquire Mexican specialty chemicals distributor Ultra Chem for an undisclosed sum. Based in Mexico City, Ultra Chem represents major global producers both in Mexico and Latin America.

 “Acquiring Ultra Chem is aligned with our strategic objectives and accomplishes two goals. It expands our overall specialty mix and extends our chemical reach into Mexico,” said David Bradley, president and CEO of Nexeo Solutions. “Ultra Chem is a strong cultural fit with complementary end markets and current margins that are immediately accretive.”

The transaction, which is subject to the usual closing conditions and regulatory approvals, is expected to close during the second quarter of 2017. Nexeo said the agreement was facilitated through a proprietary deal process.

Earlier this month, Nexeo appointed Dan Smith as its new chairman, replacing Wilbur Ross who resigned as a result of his confirmation as US Secretary of Commerce. One of Ross’s key priorities is to renegotiate the NAFTA trade agreement with Mexico and Canada. In an interview with US television channel Fox News on Mar. 12, Ross said the Trump administration has yet to determine what the replacement agreement would look like. He said the department’s goal is to update the trade deal because the current version is “outdated” and has “wrong” features.

Free Virtual Event

Batteries and Hydrogen: Competitors or Partners?
CHEManager Spotlight

Batteries and Hydrogen: Competitors or Partners?

17 September 2026 | Reserve your spot to learn where solid-state batteries and green hydrogen are headed—and how leading teams are turning them into scalable energy storage solutions.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

most read